https://www.selleckchem.com/pr....oducts/mitomycin-c.h
Hyoscine-N-butylbromide was found to be effective in shortening the duration of the first stage of labor without adverse outcomes for mother or neonate. The trial was registered with the Pan African Clinical trials Registry (PACTR), protocol number PACTR201808146688942 (https//pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=3532). Hyoscine-N-butylbromide was found to be effective in shortening the duration of the first stage of labor without adverse outcomes for mother or neonate. The trial was registered with the Pan African Clinical t
Like
Comment
Share
